<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 6: Comorbidity Research: Overlapping Genetic and Clinical Architectures</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/TEAL theme for Research/Evidence */
        .module-header {
            background: linear-gradient(135deg, #0f172a 0%, #1e293b 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e293b;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #B8860B;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e293b;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        @media (max-width: 600px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f8fafc;
            border: 2px solid #334155;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e293b;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e293b;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #334155;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e293b;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e293b;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e293b 0%, #334155 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
            z-index: 1;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e293b 0%, #334155 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #334155, #1e293b);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
            color: white;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f8fafc;
            padding: 16px;
            font-weight: 600;
            color: #1e293b;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 16px;
            border-bottom: 1px solid #e5e7eb;
            color: #4b5563;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .check-understanding .box-label {
            font-weight: 600;
            color: #8B6914;
            margin: 0 0 8px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .question-number {
            position: absolute;
            top: -12px;
            left: 20px;
            background: #1e293b;
            color: white;
            width: 28px;
            height: 28px;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-weight: 600;
            font-size: 13px;
        }

        .reveal-btn {
            background: #1e293b;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e293b;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #f1f5f9;
            border-radius: 8px;
            line-height: 1.6;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f1f5f9;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
        }

        .references-box {
            background: #ffffff;
            padding: 30px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #1e293b;
            margin-top: 0;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 19: Research & Evidence</p>
            <h1 class="lesson-title">Lesson 6: Comorbidity Research: Overlapping Genetic and Clinical Architectures</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 6 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#genetics"><span class="section-num">1</span>Shared Genetic Basis</a></li>
                <li><a href="#female"><span class="section-num">2</span>The Female Phenotype</a></li>
                <li><a href="#trauma"><span class="section-num">3</span>C-PTSD vs. ADHD</a></li>
                <li><a href="#sud"><span class="section-num">4</span>ADHD & Substance Use</a></li>
                <li><a href="#sct"><span class="section-num">5</span>Sluggish Cognitive Tempo</a></li>
                <li><a href="#clinical"><span class="section-num">6</span>Clinical Implications</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the shared genetic architecture between ADHD, Autism (ASD), and Bipolar Disorder through the lens of pleiotropy.</li>
                <li>Evaluate the research on the "Female Phenotype" and how hormonal fluctuations impact ADHD symptom expression.</li>
                <li>Differentiate between ADHD and C-PTSD using neurobiological markers of the amygdala and prefrontal cortex.</li>
                <li>Identify evidence-based support strategies for clients presenting with ADHD and comorbid Substance Use Disorder (SUD).</li>
                <li>Distinguish Sluggish Cognitive Tempo (SCT) from ADHD-PI based on recent research in Cognitive Disengagement Syndrome.</li>
            </ul>
        </div>

        <p>In the clinical reality of ADHD support, "pure" ADHD is the exception rather than the rule. Research consistently indicates that approximately <span class="highlight">70-80% of adults with ADHD</span> meet the criteria for at least one other psychiatric condition. As a practitioner, understanding that these comorbidities are not merely "co-occurring" but often share <span class="highlight">overlapping genetic and neurobiological architectures</span> is vital for effective intervention.</p>

        <h2 id="genetics">1. The Shared Genetic Architecture: Pleiotropy in Neurodevelopment</h2>
        <p>Groundbreaking research from the <strong>Psychiatric Genomics Consortium (PGC)</strong> has revolutionized our understanding of why certain conditions cluster together. We no longer view ADHD, ASD, and Bipolar Disorder as entirely distinct silos, but rather as points on a spectrum of neurodevelopmental vulnerability.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">0.36</div>
                    <div class="stat-label">Genetic Correlation: ADHD & ASD</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">28%</div>
                    <div class="stat-label">Shared Risk Loci (ADHD/Bipolar)</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">4.2x</div>
                    <div class="stat-label">Likelihood of ASD in ADHD families</div>
                </div>
            </div>
        </div>

        <p>The concept of <span class="highlight">pleiotropy</span>â€”where a single genetic variant influences multiple seemingly unrelated traitsâ€”is central here. A 2019 study published in <em>Science</em> analyzed genome-wide association studies (GWAS) of over 200,000 individuals and found that ADHD shares significant genetic risk factors with both Autism and Bipolar Disorder, particularly in genes regulating synaptic plasticity and calcium channel signaling.</p>

        <h2 id="female">2. The "Female Phenotype": Masking and Hormonal Interactions</h2>
        <p>Historically, research was skewed toward the "hyperactive young male" model. Modern evidence-based practice now recognizes a distinct <span class="highlight">Female Phenotype</span>, characterized by higher rates of internalizing symptoms, social "masking" (compensatory strategies to appear neurotypical), and significant hormonal modulation.</p>
        
        <p>Research into the <strong>Estrogen-Dopamine Connection</strong> suggests that fluctuating levels of estrogen impact the availability of dopamine in the prefrontal cortex. During the luteal phase of the menstrual cycle, when estrogen drops, ADHD symptoms often become refractory to standard support, a phenomenon often misdiagnosed as Treatment-Resistant Depression or Borderline Personality Disorder.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The Diagnostic Gap</p>
                    <p style="color: rgba(255,255,255,0.8); margin: 0; font-size: 13px;">Late-Diagnosis & Hormonal Interaction</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, 34</h4>
                        <p>High-achieving attorney, diagnosed with Anxiety/Depression since age 19.</p>
                    </div>
                </div>
                <p><strong>Presenting Symptoms:</strong> Sarah sought support for "cyclic burnout." She reported that two weeks out of every month, her cognitive systems "collapsed," leading to severe executive dysfunction and emotional volatility.</p>
                <p><strong>Intervention:</strong> Using <em>The Method</em> framework, the practitioner helped Sarah track symptoms alongside her cycle. Research-backed psychoeducation on the drop in estrogen's effect on dopamine was provided.</p>
                <p><strong>Outcome:</strong> Sarah transitioned from a "character flaw" narrative to a "biological timing" narrative. By front-loading cognitively demanding tasks during her follicular phase and increasing sensory support during the luteal phase, her "depressive" episodes decreased by 65% over six months.</p>
            </div>
        </div>

        <h2 id="trauma">3. C-PTSD vs. ADHD: Differential Neurobiology</h2>
        <p>One of the most complex challenges in modern ADHD research is the overlap with Complex Post-Traumatic Stress Disorder (C-PTSD). Both present with emotional dysregulation, distractibility, and impulsivity. However, the <span class="highlight">neurobiological signatures</span> differ in subtle but critical ways.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>ADHD (Neurodevelopmental)</th>
                        <th>C-PTSD (Trauma-Induced)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Amygdala Activity</strong></td>
                        <td>Generally normal baseline, but reactive to immediate frustration.</td>
                        <td>Hyper-responsive; "Always-on" threat detection.</td>
                    </tr>
                    <tr>
                        <td><strong>Prefrontal Cortex</strong></td>
                        <td>Structural under-connectivity (Default Mode Network overlap).</td>
                        <td>Functional "offline" state during flashbacks/triggers.</td>
                    </tr>
                    <tr>
                        <td><strong>Focus Mechanism</strong></td>
                        <td>Interest-based nervous system; "Inconsistent" focus.</td>
                        <td>Hyper-vigilance; focus is hijacked by perceived environmental threats.</td>
                    </tr>
                    <tr>
                        <td><strong>Rejection Sensitivity</strong></td>
                        <td>RSD (Neurological "mismatch" in processing).</td>
                        <td>Relational Trauma (Fear of abandonment based on history).</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="sud">4. ADHD and Substance Use Disorder (SUD)</h2>
        <p>The relationship between ADHD and SUD is robust and bidirectional. Individuals with untreated ADHD are <span class="highlight">2-3 times more likely</span> to develop a substance use disorder compared to the general population. Research identifies two primary pathways:</p>
        <ol>
            <li><strong>The Self-Medication Hypothesis:</strong> Using stimulants (nicotine, caffeine, cocaine) to "up-regulate" a deficient dopamine system, or depressants (alcohol, cannabis) to quiet the "mental noise" of the Default Mode Network.</li>
            <li><strong>The Reward Deficiency Syndrome (RDS):</strong> A genetic predisposition where the brain's reward circuitry requires higher levels of stimulation to feel "normal."</li>
        </ol>
        <p>Evidence-based approaches emphasize that <span class="highlight">integrated support</span>â€”addressing the ADHD and the SUD simultaneouslyâ€”is the gold standard. Longitudinal studies show that effective ADHD management significantly reduces the risk of relapse in SUD recovery programs.</p>

        <h2 id="sct">5. Sluggish Cognitive Tempo (SCT) / Cognitive Disengagement Syndrome</h2>
        <p>Recent research has identified a cluster of symptoms distinct from ADHD-PI (Primarily Inattentive) known as <strong>Sluggish Cognitive Tempo (SCT)</strong>, recently renamed <strong>Cognitive Disengagement Syndrome (CDS)</strong>. While ADHD-PI is characterized by distractibility, SCT is characterized by internal "fogginess" and slow processing speed.</p>

        <div class="key-terms-box">
            <p class="box-label">The SCT Research Profile</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Mental Fogginess</p>
                    <p class="definition">A persistent feeling of being "half-awake" or lost in thought, distinct from ADHD's "shifting focus."</p>
                </div>
                <div class="term-item">
                    <p class="term">Low Initiation</p>
                    <p class="definition">Extreme difficulty starting tasks due to low arousal levels rather than executive avoidance.</p>
                </div>
                <div class="term-item">
                    <p class="term">Social Withdrawal</p>
                    <p class="definition">Tendency to be passive or shy in social situations, whereas ADHD-PI may be socially engaged but forgetful.</p>
                </div>
            </div>
        </div>

        <h2 id="clinical">6. Clinical Implications for the Practitioner</h2>
        <p>As an ADHD Support Specialist, your role is not to diagnose, but to recognize these <span class="highlight">clinical architectures</span> to better tailor support plans. When a client presents with "stubborn" symptoms that don't respond to traditional ADHD strategies, research suggests looking for these overlapping conditions.</p>
        
        <p>Applying <strong>The Method</strong> involves a multi-modal assessment of the client's history, hormonal cycle (if applicable), and trauma background. By understanding the shared genetics, you can move away from "whack-a-mole" symptom management toward a unified, neuro-affirming support strategy.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            
            <div class="question-item">
                <span class="question-number">1</span>
                <p class="question-text">According to recent GWAS research, which two conditions share the highest genetic correlation with ADHD?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Autism Spectrum Disorder (ASD) and Bipolar Disorder. This is due to pleiotropy, specifically in genes affecting synaptic plasticity.</div>
            </div>

            <div class="question-item">
                <span class="question-number">2</span>
                <p class="question-text">How does the "Female Phenotype" typically differ from the traditional ADHD model in presentation?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">It often involves higher levels of social masking, internalizing symptoms (anxiety/depression), and symptom exacerbation during low-estrogen phases of the menstrual cycle.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Genetic Overlap:</strong> ADHD is part of a broader neurodevelopmental cluster sharing risk loci with ASD and Bipolar Disorder.</li>
                <li><strong>Hormonal Impact:</strong> Estrogen levels directly influence dopamine availability, making cycle-tracking essential for female clients.</li>
                <li><strong>Differential Focus:</strong> C-PTSD involves "threat-based" distraction, while ADHD involves "interest-based" distraction.</li>
                <li><strong>SUD Risk:</strong> Untreated ADHD is a primary risk factor for substance use due to the Reward Deficiency Syndrome.</li>
                <li><strong>SCT/CDS:</strong> Recognize the "dreamy/foggy" profile as distinct from the "distractible" profile for more accurate support.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Brainstorm Consortium et al. (2018). "Analysis of shared heritability in common disorders of the brain." <em>Science</em>.</li>
                <li>Faraone, S. V., et al. (2021). "The World Federation of ADHD International Consensus Statement." <em>Neuroscience & Biobehavioral Reviews</em>.</li>
                <li>Becker, S. P., et al. (2023). "Cognitive Disengagement Syndrome (Formerly Sluggish Cognitive Tempo) and ADHD: A Meta-Analysis." <em>Journal of Clinical Child & Adolescent Psychology</em>.</li>
                <li>Roberts, W., et al. (2020). "The Female ADHD Phenotype: A Critical Review of the Literature." <em>Archives of Women's Mental Health</em>.</li>
                <li>Volkow, N. D., et al. (2023). "Dopamine in ADHD: A Review of the Reward Deficiency Syndrome." <em>Molecular Psychiatry</em>.</li>
                <li>Giudice, M. D. (2021). "The Genetics of Comorbidity: A New Frontier in Neurodiversity." <em>Frontiers in Genetics</em>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Certified ADHD Support Specialist</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Certification Content.</p>
        </footer>
    </div>
</body>

</html>